Clinical Trial Update: Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cyclophosphamide, methotrexate, and prednisolone with or without aromatase inhibitor therapy in postmenopausal women with meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor therapy (aromatase inhibitor)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)
• Prednisolone (Prednisolone)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN